Intimation for the closure of the trading window in terms of SEBI (Prohibition of Insider Trading ) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bharat Parenterals Ltd has informed the BSE that its trading window for dealing in equity shares will be closed from Wednesday, April 01, 2026, until 48 hours after the declaration of the audited financial results (standalone and consolidated) for the quarter and year ending March 31, 2026. This closure is mandated under the SEBI (Prohibition of Insider Trading) Regulations, 2015, and applies to all Designated Persons and their immediate relatives, who are barred from trading in the company's shares during this period. The PANs of these persons will also be frozen at the CDSL depository portal during the closure. The date of the board meeting to approve the audited results will be communicated later.
This is a routine regulatory filing, not an actionable corporate event. It signals that the company's full-year and Q4 FY26 audited results are imminent, which could be a catalyst for stock price movement once announced. Retail investors should note that insiders cannot trade during this period, which is standard practice before results.